Trastuzumab Deruxtecan in Patients From China With Pretreated HER2-Mutant Non–Small Cell Lung Cancer: Final Analysis of the Phase 2, Single-Arm DESTINY-Lung05 Trial
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-08-23 23:33:01 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.cllc.2026.06.003
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S1525730426000835
其他信息:
出版社: Elsevier BV
作者: Ying Liu; Dairong Li; Lin Wu; Xingya Li; Yun Fan; Mingjun Zhang; Jun Guo; Yu Yao; Jian Fang; Ke-Jing Tang; Feng Luo; Yan Yu; Xuhong Min; Zizheng Song; Jie Hu; Rui Ma; Huaping Yang; Yongqian Shu; Ruilian Xu; Buhai Wang; Xiaorong Dong; Yunru Chen; Rui Mao; Victor Zhang; Yong Fang
